CTLA-4 blockade: therapeutic potential in cancer treatments

par Tarhini, Ahmad A, Iqbal, Fatima
Publié 2010

Anticancer Cytokines: Biology and Clinical Effects of IFN-α2, IL-2, IL-15, IL-21, and IL-12

par Floros, Theofanis, Tarhini, Ahmad A.
Publié dans Semin Oncol (2015)

The use of immunotherapy in the treatment of melanoma

par Achkar, Tala, Tarhini, Ahmad A.
Publié dans J Hematol Oncol (2017)

Clinical and Immunologic Basis of Interferon Therapy in Melanoma

par Tarhini, Ahmad A., Kirkwood, John M.
Publié 2009

Adjuvant Therapy for Melanoma

par Davar, Diwakar, Tarhini, Ahmad A., Kirkwood, John M.
Publié 2012

IFN-α in the Treatment of Melanoma

par Tarhini, Ahmad A., Gogas, Helen, Kirkwood, John M.
Publié dans J Immunol (2012)

Immune Checkpoint Blockade and Interferon-α in Melanoma

par Rafique, Imran, Kirkwood, John M, Tarhini, Ahmad A
Publié dans Semin Oncol (2015)

Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694

par Tarhini, Ahmad A., Stuckert, Joseph, Lee, Sandra, Sander, Cindy, Kirkwood, John M.
Publié 2009

Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients

par Mehta, Kathan, Appleman, Leonard, Wang, Hong, Tarhini, Ahmad A., Parikh, Rahul A.
Publié dans PLoS One (2016)

The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients

par Khunger, Arjun, Rytlewski, Julie A., Fields, Paul, Yusko, Erik C., Tarhini, Ahmad A.
Publié dans Oncoimmunology (2019)

Immunotherapy of Cancer in 2012

par Kirkwood, John M., Butterfield, Lisa H., Tarhini, Ahmad A., Zarour, Hassane, Kalinski, Pawel, Ferrone, Soldano
Publié 2012

Neoadjuvant therapy of locally/regionally advanced melanoma

par Khunger, Arjun, Buchwald, Zachary S., Lowe, Michael, Khan, Mohammad K., Delman, Keith A., Tarhini, Ahmad A.
Publié dans Ther Adv Med Oncol (2019)

Long-term control of leptomeningeal disease after radiation therapy and nivolumab in a metastatic melanoma patient

par Wu, Richard C, Newman, William, Patanowitz, Liron, Branstetter, Barton F, Amankulor, Nduka, Tarhini, Ahmad A
Publié dans Immunotherapy (2020)

Differing Patterns of Circulating Regulatory T-Cells and Myeloid Derived Suppressor Cells in Metastatic Melanoma Patients Receiving Anti-CTLA4 Antibody and Interferon-α or TLR-9 Ag...

par Tarhini, Ahmad A, Butterfield, Lisa H., Shuai, Yongli, Gooding, William E., Kalinski, Pawel, Kirkwood, John M
Publié 2012

Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfa

par Tarhini, Ahmad A., Shin, Donghoon, Lee, Sandra J., Stuckert, Joseph, Sander, Cindy A., Kirkwood, John M.
Publié dans Melanoma Res (2014)

Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab

par Retseck, Janet, VanderWeele, Robert, Lin, Hui-Min, Lin, Yan, Butterfield, Lisa H., Tarhini, Ahmad A.
Publié dans J Immunother Cancer (2016)

Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab

par Najjar, Yana G., Ding, Fei, Lin, Yan, VanderWeele, Robert, Butterfield, Lisa H., Tarhini, Ahmad A.
Publié dans J Transl Med (2017)

Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma

par Retseck, Janet, Nasr, Alexis, Lin, Yan, Lin, Huang, Mendiratta, Prateek, Butterfield, Lisa H., Tarhini, Ahmad A.
Publié dans J Transl Med (2018)

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

par Tarhini, Ahmad A., Zahoor, Haris, Lin, Yan, Malhotra, Usha, Sander, Cindy, Butterfield, Lisa H., Kirkwood, John M.
Publié dans J Immunother Cancer (2015)

Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)

par Anker, Christopher J., Grossmann, Kenneth F., Atkins, Michael B., Suneja, Gita, Tarhini, Ahmad A., Kirkwood, John M.
Publié dans Int J Radiat Oncol Biol Phys (2016)